Vitamin D Status and Lipid Profile in Obese Adults With Type 2 Diabetes
NCT07729553 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 150
Last updated 2026-07-27
Summary
This prospective, single-center, cross-sectional observational study aims to evaluate the association between serum 25-hydroxyvitamin D concentrations and lipid profile parameters among adults with obesity and established type 2 diabetes mellitus. A total of 160 participants will be recruited from an outpatient diabetes clinic in Cairo, Egypt. Each participant will undergo a single clinical, anthropometric, and laboratory assessment. No intervention or treatment will be assigned by the investigators.
Conditions
- Type 2 Diabetes Mellitus
- Obesity
- Dyslipidemia
- Vitamin D Deficiency
Sponsors & Collaborators
-
Sinai University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-07-25
- Primary Completion
- 2026-12-30
- Completion
- 2027-02-28
More Related Trials
-
Alpha-lipoic Acid in Diabetic Nephropathy
NCT06253429 ·Status: RECRUITING ·Phase: PHASE3
-
n-3 Fatty Acid Infusion and Type 2 Diabetes
NCT00829569 ·Status: COMPLETED ·Phase: NA
-
Nicotinamide in Non-Alcoholic Fatty Liver Disease Patients
NCT03850886 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Vitamin D Supplementation on SOD,IL-6 and Insulin Resistance in Type 2 Diabetes Mellitus (DM)
NCT05596383 ·Status: UNKNOWN ·Phase: NA
-
Effects of Docosahexaenoic Acid (DHA) on Cardiovascular Disease on Diabetic Patients
NCT01150292 ·Status: COMPLETED ·Phase: NA
-
Mitochondrial Effects of C18:0 Supplementation in Humans
NCT02957838 ·Status: COMPLETED ·Phase: NA
-
The Effects of DPPIs on Cognitive Function of Diabetic Patients
NCT06164535 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Ursodiol on Insulin Sensitivity, Gastric Emptying and Body Weight With Type 2 Diabetes on Metformin
NCT02033876 ·Status: COMPLETED ·Phase: PHASE2
-
Krill Oil and Muscle Weakness in Type 2 Diabetes
NCT04943523 ·Status: UNKNOWN ·Phase: NA
-
The Effects of Lipoic Acid on Glycaemic Control in Type 2 Diabetes
NCT00398892 ·Status: WITHDRAWN ·Phase: PHASE2
-
COVID-19 Infection in Diabetic Patients
NCT04765254 ·Status: UNKNOWN
-
Examination of the Anti-inflammatory and Insulin Sensitizing Properties of Doxycycline in Humans
NCT01375491 ·Status: COMPLETED ·Phase: PHASE4
-
Trial of Leptin Replacement Therapy in Patients With Lipodystrophy
NCT00896298 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Cyclophosphamide in the Treatment of Associated Acquired Lipodystrophy Syndrome With Type 1 Diabetes
NCT03936829 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
The Use of Statin in Diabetic Patients Not Known to Have Atherosclerotic Cardiovascular Disease
NCT06676683 ·Status: NOT_YET_RECRUITING
-
Effect of Endoplasmic Reticulum Stress on Metabolic Function
NCT00771901 ·Status: COMPLETED ·Phase: NA
-
A Study to Investigate Effects of Omega-3 Carboxylic Acids and Dapagliflozin on Liver Fat Content in Diabetic Patients
NCT02279407 ·Status: COMPLETED ·Phase: PHASE2
-
Alpha Lipoic Acid Supplementation and Metabolic Syndrome
NCT03589690 ·Status: UNKNOWN ·Phase: NA
-
DPP4 Inhibitor and Coronary Atherosclerosis in Patients Receiving Insulin Therapy
NCT04825795 ·Status: COMPLETED
-
Study to Evaluate Safety and Efficacy of PreCrea® on Subjects With Higher Than Normal Blood Sugar Levels
NCT02189005 ·Status: COMPLETED ·Phase: PHASE3
-
The Effects of Coffee Main Constituents (Caffeine and Chlorogenic Acid) Supplementation on Inflammatory, Metabolic Factors, Hepatic Steatosis and Fibrosis in None- Alcoholic Fatty Liver Patients With Type 2 Diabetes
NCT02929901 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Pilot Study on Metabolic Effects of Fish Peptides and Vitamin D
NCT02668159 ·Status: COMPLETED ·Phase: NA
-
A Study to Characterize the Pharmacokinetics/Pharmacodynamics and Effect of Food of DA-1229 in Healthy Male Subjects
NCT00961025 ·Status: UNKNOWN ·Phase: PHASE1
-
Spectroscopic and Colorimetric Analysis of Acanthosis Nigricans in Patients With Hyperinsulinemia
NCT01125150 ·Status: COMPLETED
-
Evaluating the Efficacy and Safety of Dehypotin® in the Patients With Type 2 Diabetes Mellitus or Cardiovascular Disease
NCT01108978 ·Status: TERMINATED ·Phase: PHASE4